[Back to Issue 11 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]

Monoclonal Antibody Targeting the HA191/199 Region of H1N1 Influenza Virus Mediates the Damage of Neural Cells

Chun-Yan Guo1,2,a*, Qing Feng1,2, Li-Ting Yan1,2, Xin Xie3, Dao-Yan Liang1,2, Yan Li1,2, Yang-Meng Feng1,2, Li-Jun Sun1,2,b*, and Jun Hu1,2,c*

1Central Laboratory of Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi 710068, China

2Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi’an, Shaanxi 710068, China

3Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, Shaanxi 710069, China

* To whom correspondence should be addressed.

Received June 29, 2021; Revised September 30, 2021; Accepted September 30, 2021
Vaccination is the most effective mean of preventing influenza virus infections. However, vaccination-induced adverse reactions of the nervous system, the causes of which are unknown, lead to concerns on the safety of influenza A vaccine. In this study, we used flow cytometry, cell ELISA, and immunofluorescence to find that H1-84 monoclonal antibody (mAb) against the191/199 region of the H1N1 influenza virus hemagglutinin (HA) protein binds to neural cells and mediates cell damage. Using molecular simulation software, such as PyMOL and PDB viewer, we demonstrated that the HA191/199 region maintains the overall structure of the HA head. Since the HA191/199 region cannot be removed from the HA structure, it has to be altered via introducing point mutations by site-directed mutagenesis. This will provide an innovative theoretical support for the subsequent modification the influenza A vaccine for increasing its safety.
KEY WORDS: influenza A virus, HA191/199 region, monoclonal antibodies (mAbs), neuronal cell damage

DOI: 10.1134/S0006297921110109